Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ANRO
ANRO
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
ANRO News
Alto Completes Patient Enrollment for ALTO-101 Clinical Trial
2d ago
Newsfilter
Healthcare Stocks Surge in After-Hours Trading
Jan 28 2026
NASDAQ.COM
Alto Neuroscience and Others Under Investigation for Shareholder Claims
Jan 20 2026
Globenewswire
Alto Neuroscience Secures Patent for ALTO-207, Enhancing Depression Treatment Potential
Jan 14 2026
Businesswire
Alto Neuroscience Secures Patent for ALTO-207, Protecting Key Treatment Method Until Mid-2040s
Jan 14 2026
Newsfilter
Alto Neuroscience Grants 150,000 Stock Options at $12.80 to New Employee
Dec 03 2025
Newsfilter
Johnson Fistel, PLLP Launches Investigation for Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Dow Inc. (DOW), and Fly-E Group, Inc. (FLYE)
Dec 01 2025
Globenewswire
Major Stocks on the Rise Monday: Jazz Pharmaceuticals, Sigma Lithium, Zymeworks, and More
Nov 17 2025
Benzinga
Alto Neuroscience Analyst Starts Coverage Optimistically; Check Out the Top 5 Initiations for Monday
Nov 17 2025
Benzinga
BTIG Begins Coverage of Alto Neuroscience with a Buy Rating and $27 Price Target
Nov 17 2025
Yahoo Finance
Jefferies Keeps Buy Rating on Alto Neuroscience and Increases Price Target to $25
Nov 12 2025
Benzinga
Alto Neuroscience Announces Financial Results and Key Business Developments for Q3 2025
Nov 12 2025
Newsfilter
NYSE Content Advisory: Pre-Market Update + Government Shutdown Nears End After 42 Days
Nov 11 2025
PRnewswire
HC Wainwright & Co. Reaffirms Buy Rating on Alto Neuroscience, Increases Price Target to $50
Oct 24 2025
Benzinga
Baird Continues to Recommend Outperform for Alto Neuroscience (ANRO)
Oct 21 2025
NASDAQ.COM
Baird Keeps Outperform Rating on Alto Neuroscience and Increases Price Target to $16
Oct 20 2025
Benzinga
Show More News
